Thomas S. Lam - Dec 5, 2022 Form 4 Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role: President and Co-CEO, Director
Signature: /s/ Thomas S. Lam
Stock symbol: AMEH
Transactions as of: Dec 5, 2022
Transactions value $: $1,048,865
Form type: 4
Date filed: 12/7/2022, 06:04 PM
Previous filing: Dec 6, 2022
Next filing: Dec 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMEH	Common Stock	Options Exercise	$514K	+51.4K	+26.82%	$10.00	243K	Dec 5, 2022	Direct
transaction	AMEH	Common Stock	Options Exercise	$534K	+48.6K	+19.97%	$11.00	292K	Dec 5, 2022	Direct
holding	AMEH	Common Stock						1.11M	Dec 5, 2022	By the Thomas and Jeanette Lam 2002 Family Trust
holding	AMEH	Common Stock						10.2M	Dec 5, 2022	By Allied Physicians of California, A Professional Medical Corporation	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMEH	Warrants to purchase Common Stock	Options Exercise		-51.4K	-100%		0	Dec 5, 2022	Common Stock	51.4K	$10.00	Direct	F2
transaction	AMEH	Warrants to purchase Common Stock	Options Exercise		-48.6K	-100%		0	Dec 5, 2022	Common Stock	48.6K	$11.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are beneficially owned by Allied Physicians of California, A Profession Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2	On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).

Content

These securities are beneficially owned by Allied Physicians of California, A Profession Medical Corporation, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

On December 8, 2017, a reverse merger transaction between the Issuer and Network Medical Management, Inc. ("NMM") was consummated such that NMM became a wholly-owned subsidiary of the Issuer (the "Merger). Immediately prior to the closing of the Merger, the Reporting Person was a shareholder of NMM. Pursuant to the Merger, the shares of NMM common stock previously held by Reporting Person were converted into (i) 1,563,763 shares of common stock of the Issuer, (ii) a warrant to purchase 48,585.84 shares of common stock of the Issuer at an exercise price of $11.00 per share , (iii) a warrant to purchase 51,443.83 shares of common stock of the Issuer at an exercise price of $10.00 per share, (iv) cash in lieu of fractional shares, and (v) the Reporting Person's pro rata portion, if any, of the holdback shares of common stock of the Issuer (such pro rata portion of the holdback shares would, without offset, initially be equal to 173,751.48 shares of common stock of the Issuer).